Maryland State Retirement & Pension System bought a new stake in shares of Natus Medical Incorporated (NASDAQ:NTUS) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 13,538 shares of the company’s stock, valued at approximately $344,000.
A number of other institutional investors also recently added to or reduced their stakes in the business. New York State Teachers Retirement System increased its stake in Natus Medical by 0.8% during the 3rd quarter. New York State Teachers Retirement System now owns 73,880 shares of the company’s stock valued at $1,853,000 after buying an additional 577 shares during the period. Strs Ohio increased its stake in Natus Medical by 10.4% during the 3rd quarter. Strs Ohio now owns 35,000 shares of the company’s stock valued at $877,000 after buying an additional 3,300 shares during the period. Pacer Advisors Inc. acquired a new position in Natus Medical during the 3rd quarter valued at about $1,365,000. Tributary Capital Management LLC increased its stake in Natus Medical by 8.6% during the 3rd quarter. Tributary Capital Management LLC now owns 442,815 shares of the company’s stock valued at $11,106,000 after buying an additional 35,006 shares during the period. Finally, Louisiana State Employees Retirement System increased its stake in Natus Medical by 6.5% during the 3rd quarter. Louisiana State Employees Retirement System now owns 16,400 shares of the company’s stock valued at $411,000 after buying an additional 1,000 shares during the period. 91.20% of the stock is currently owned by hedge funds and other institutional investors.
In other news, insider Dong Chune Christopher Chung sold 11,787 shares of Natus Medical stock in a transaction that occurred on Thursday, December 9th. The shares were sold at an average price of $23.08, for a total value of $272,043.96. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 2.00% of the company’s stock.
Separately, Zacks Investment Research cut shares of Natus Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, November 10th.
Shares of NTUS opened at $24.77 on Monday. The stock has a 50 day simple moving average of $24.68. The firm has a market cap of $845.95 million, a PE ratio of 51.61 and a beta of 0.54. Natus Medical Incorporated has a 12-month low of $19.03 and a 12-month high of $29.70.
Natus Medical (NASDAQ:NTUS) last announced its quarterly earnings data on Thursday, November 4th. The company reported $0.28 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.30 by ($0.02). The business had revenue of $113.88 million during the quarter, compared to analyst estimates of $116.60 million. Natus Medical had a return on equity of 9.07% and a net margin of 3.59%. During the same period in the prior year, the firm earned $0.09 EPS. As a group, sell-side analysts forecast that Natus Medical Incorporated will post 1.15 earnings per share for the current year.
Natus Medical Company Profile
Natus Medical, Inc provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Featured Article: What sectors are represented in the Nikkei Index?
Want to see what other hedge funds are holding NTUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Incorporated (NASDAQ:NTUS).
Want More Great Investing Ideas?